Status:
TERMINATED
Gender Identity and Own Body Perception
Lead Sponsor:
University of California, Los Angeles
Conditions:
Gender Dysphoria
Eligibility:
All Genders
18-40 years
Brief Summary
This study will provide valuable information on the neurobiological underpinning of gender dysphoria (GD) and the effects of sex hormones, and promises to uncover functional or structural neural patte...
Detailed Description
The purpose of this study is to understand the neurobiology of gender dysphoria (GD) and the interactions between cross hormone treatment, the brain, and the body phenotype. The investigators also aim...
Eligibility Criteria
Inclusion
- Participants with gender dysphoria (GD)
- Females and males from any racial or ethnic background, between the ages of 18 years and 40 years.
- Participants must meet Diagnostic and Statistical Manual-5 criteria for GD (302.85)
- Intelligence quotient (IQ) \> 80
- Participants with GD
Exclusion
- Previous or on-going sex hormone medication
- Previous sex reassignment surgery
- Oral contraceptives
- Participants with GD are not be taking any other psychotropic medication. (No participant will be recommended to discontinue or taper medications for the purpose of participating in the study.)
- Irregular menstrual cycles
- Control participants
- Inclusion Criteria:
- Females and males from any racial or ethnic background, between the ages of 18 and 40.
- IQ \> 80
- Control participants
Key Trial Info
Start Date :
February 22 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT04374708
Start Date
February 22 2018
End Date
December 31 2021
Last Update
March 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA
Los Angeles, California, United States, 90095